Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DW1029M in Diabetic Nephropathy
NCT01935167Phase 2Completed
- Sponsor
- Dongwha Pharmaceutical Co., Ltd.
- Start
- Oct 2013
- Primary completion
- Aug 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of DW1029M in diabetic nephropathy (DN), sponsored by Dongwha Pharmaceutical Co., Ltd.. Started Oct 2013; status: completed.
02
Drugs
DW1029M
03
Conditions
diabetic nephropathy (DN)
Beyond the preview
Go deeper on NCT01935167.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01935167.